188 related articles for article (PubMed ID: 35063131)
1. Selective elimination of pluripotent stem cells by PIKfyve specific inhibitors.
Chakraborty AR; Vassilev A; Jaiswal SK; O'Connell CE; Ahrens JF; Mallon BS; Pera MF; DePamphilis ML
Stem Cell Reports; 2022 Feb; 17(2):397-412. PubMed ID: 35063131
[TBL] [Abstract][Full Text] [Related]
2. PIP5K1C phosphoinositide kinase deficiency distinguishes PIKFYVE-dependent cancer cells from non-malignant cells.
Roy A; Chakraborty AR; Nomanbhoy T; DePamphilis ML
Autophagy; 2023 Sep; 19(9):2464-2484. PubMed ID: 36803256
[TBL] [Abstract][Full Text] [Related]
3. A family of PIKFYVE inhibitors with therapeutic potential against autophagy-dependent cancer cells disrupt multiple events in lysosome homeostasis.
Sharma G; Guardia CM; Roy A; Vassilev A; Saric A; Griner LN; Marugan J; Ferrer M; Bonifacino JS; DePamphilis ML
Autophagy; 2019 Oct; 15(10):1694-1718. PubMed ID: 30806145
[TBL] [Abstract][Full Text] [Related]
4. Combined Inhibition of p38MAPK and PIKfyve Synergistically Disrupts Autophagy to Selectively Target Cancer Cells.
O'Connell CE; Vassilev A
Cancer Res; 2021 Jun; 81(11):2903-2917. PubMed ID: 33685990
[TBL] [Abstract][Full Text] [Related]
5. PIKFYVE inhibitors trigger interleukin-24-dependent cell death of autophagy-dependent melanoma.
Roy A; Chakraborty AR; DePamphilis ML
Mol Oncol; 2024 Apr; 18(4):988-1011. PubMed ID: 38414326
[TBL] [Abstract][Full Text] [Related]
6. Geminin Is Essential for Pluripotent Cell Viability During Teratoma Formation, but Not for Differentiated Cell Viability During Teratoma Expansion.
Adler-Wailes DC; Kramer JA; DePamphilis ML
Stem Cells Dev; 2017 Feb; 26(4):285-302. PubMed ID: 27821018
[TBL] [Abstract][Full Text] [Related]
7. Nuclear magnetic resonance detects phosphoinositide 3-kinase/Akt-independent traits common to pluripotent murine embryonic stem cells and their malignant counterparts.
Romanska HM; Tiziani S; Howe RC; Günther UL; Gulzar Z; Lalani el-N
Neoplasia; 2009 Dec; 11(12):1301-8. PubMed ID: 20019838
[TBL] [Abstract][Full Text] [Related]
8. [Antiproliferative and cytotoxic effects of different type cytostatics on mouse pluripotent stem and teratocarcinoma cells].
Gordeeva OF
Ontogenez; 2012; 43(4):268-77. PubMed ID: 23035583
[TBL] [Abstract][Full Text] [Related]
9. Akebia saponin E, as a novel PIKfyve inhibitor, induces lysosome-associated cytoplasmic vacuolation to inhibit proliferation of hepatocellular carcinoma cells.
Peng P; Jia D; Cao L; Lu W; Liu X; Liang C; Pan Z; Fang Z
J Ethnopharmacol; 2021 Feb; 266():113446. PubMed ID: 33031902
[TBL] [Abstract][Full Text] [Related]
10. Identification of chemicals inducing cardiomyocyte proliferation in developmental stage-specific manner with pluripotent stem cells.
Uosaki H; Magadum A; Seo K; Fukushima H; Takeuchi A; Nakagawa Y; Moyes KW; Narazaki G; Kuwahara K; Laflamme M; Matsuoka S; Nakatsuji N; Nakao K; Kwon C; Kass DA; Engel FB; Yamashita JK
Circ Cardiovasc Genet; 2013 Dec; 6(6):624-33. PubMed ID: 24141057
[TBL] [Abstract][Full Text] [Related]
11. Generation of pluripotent cancer-initiating cells from transformed bone marrow-derived cells.
Liu C; Xu S; Ma Z; Zeng Y; Chen Z; Lu Y
Cancer Lett; 2011 Apr; 303(2):140-9. PubMed ID: 21339043
[TBL] [Abstract][Full Text] [Related]
12. Rediscovering pluripotency: from teratocarcinomas to embryonic stem cells. Cardiff, 10-12 October 2011.
Barbaric I; Harrison NJ
Int J Dev Biol; 2012; 56(4):197-206. PubMed ID: 22562197
[TBL] [Abstract][Full Text] [Related]
13. [Regulation of in vitro and in vivo differentiation of mouse embryonic stem cells, embryonic germ cells, and teratocarcinoma cells by TGFb family signaling factors].
Gordeeva OF; Nikonova TM; Lifantseva NV
Ontogenez; 2009; 40(6):403-18. PubMed ID: 20058783
[TBL] [Abstract][Full Text] [Related]
14. Lysosome enlargement during inhibition of the lipid kinase PIKfyve proceeds through lysosome coalescence.
Choy CH; Saffi G; Gray MA; Wallace C; Dayam RM; Ou ZA; Lenk G; Puertollano R; Watkins SC; Botelho RJ
J Cell Sci; 2018 May; 131(10):. PubMed ID: 29661845
[TBL] [Abstract][Full Text] [Related]
15. Cell-cell signaling through NOTCH regulates human embryonic stem cell proliferation.
Fox V; Gokhale PJ; Walsh JR; Matin M; Jones M; Andrews PW
Stem Cells; 2008 Mar; 26(3):715-23. PubMed ID: 18055449
[TBL] [Abstract][Full Text] [Related]
16. Aza-deoxycytidine induces apoptosis or differentiation via DNMT3B and targets embryonal carcinoma cells but not their differentiated derivatives.
Wongtrakoongate P; Li J; Andrews PW
Br J Cancer; 2014 Apr; 110(8):2131-8. PubMed ID: 24603304
[TBL] [Abstract][Full Text] [Related]
17. Selective proapoptotic activity of polyphenols from red wine on teratocarcinoma cell, a model of cancer stem-like cell.
Sharif T; Auger C; Bronner C; Alhosin M; Klein T; Etienne-Selloum N; Schini-Kerth VB; Fuhrmann G
Invest New Drugs; 2011 Apr; 29(2):239-47. PubMed ID: 19943082
[TBL] [Abstract][Full Text] [Related]
18. Novel histone demethylase LSD1 inhibitors selectively target cancer cells with pluripotent stem cell properties.
Wang J; Lu F; Ren Q; Sun H; Xu Z; Lan R; Liu Y; Ward D; Quan J; Ye T; Zhang H
Cancer Res; 2011 Dec; 71(23):7238-49. PubMed ID: 21975933
[TBL] [Abstract][Full Text] [Related]
19. Apoptotic susceptibility to DNA damage of pluripotent stem cells facilitates pharmacologic purging of teratoma risk.
Smith AJ; Nelson NG; Oommen S; Hartjes KA; Folmes CD; Terzic A; Nelson TJ
Stem Cells Transl Med; 2012 Oct; 1(10):709-18. PubMed ID: 23197662
[TBL] [Abstract][Full Text] [Related]
20. [Comparative analysis of expression of TGFbeta family factors and their receptors in mouse embryonic stem and embryonic teratocarcinoma cells].
Krasnikova NIu; Gordeeva OF
Ontogenez; 2007; 38(2):126-35. PubMed ID: 17479535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
